• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

果胶处理重塑肠道微生物群可改善肥胖小鼠的肝脂肪变性。

Gut Microbiota Reshaped by Pectin Treatment Improves Liver Steatosis in Obese Mice.

机构信息

Université Paris-Saclay, Inserm U996, Inflammation, Microbiome and Immunosurveillance, 32 rue des carnets, 92140 Clamart, France.

AP-HP, Hepato-Gastroenterology and Nutrition, Hôpital Antoine-Béclère, 92140 Clamart, France.

出版信息

Nutrients. 2021 Oct 22;13(11):3725. doi: 10.3390/nu13113725.

DOI:10.3390/nu13113725
PMID:34835981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8621973/
Abstract

Pectin, a soluble fiber, improves non-alcoholic fatty-liver disease (NAFLD), but its mechanisms are unclear. We aimed to investigate the role of pectin-induced changes in intestinal microbiota (IM) in NAFLD. We recovered the IM from mice fed a high-fat diet, treated or not with pectin, to perform a fecal microbiota transfer (FMT). Mice fed a high-fat diet, which induces NAFLD, were treated with pectin or received a fecal microbiota transfer (FMT) from mice treated with pectin before (preventive FMT) or after (curative FMT) being fed a high-fat diet. Pectin prevented the development of NAFLD, induced browning of adipose tissue, and modified the IM without increasing the abundance of proteobacteria. Preventive FMT also induced browning of white adipose tissue but did not improve liver steatosis, in contrast to curative FMT, which induced an improvement in steatosis. This was associated with an increase in the concentration of short-chain fatty acids (SCFAs), in contrast to preventive FMT, which induced an increase in the concentration of branched SCFAs. Overall, we show that the effect of pectin may be partially mediated by gut bacteria.

摘要

果胶是一种可溶性纤维,可改善非酒精性脂肪性肝病(NAFLD),但其机制尚不清楚。我们旨在研究果胶诱导的肠道微生物群(IM)变化在 NAFLD 中的作用。我们从喂食高脂肪饮食的小鼠中回收 IM,并对其进行果胶处理或不处理,以进行粪便微生物群转移(FMT)。喂食高脂肪饮食的小鼠会引发 NAFLD,这些小鼠接受果胶治疗或接受先前(预防性 FMT)或之后(治疗性 FMT)喂食高脂肪饮食的小鼠的粪便微生物群转移(FMT)。果胶可预防 NAFLD 的发生,诱导脂肪组织褐变,并改变 IM,而不会增加变形菌门的丰度。预防性 FMT 也可诱导白色脂肪组织褐变,但与治疗性 FMT 不同,后者可改善肝脂肪变性。这与短链脂肪酸(SCFA)浓度的增加有关,而预防性 FMT 则会导致支链 SCFA 浓度增加。总体而言,我们表明果胶的作用可能部分通过肠道细菌介导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/60d7292dc408/nutrients-13-03725-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/d023e6a1db72/nutrients-13-03725-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/a6808cf6275a/nutrients-13-03725-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/d9f48af61097/nutrients-13-03725-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/6486f564ca9f/nutrients-13-03725-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/c0d2d187455a/nutrients-13-03725-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/8a81ad6eced8/nutrients-13-03725-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/60d7292dc408/nutrients-13-03725-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/d023e6a1db72/nutrients-13-03725-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/a6808cf6275a/nutrients-13-03725-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/d9f48af61097/nutrients-13-03725-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/6486f564ca9f/nutrients-13-03725-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/c0d2d187455a/nutrients-13-03725-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/8a81ad6eced8/nutrients-13-03725-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51d/8621973/60d7292dc408/nutrients-13-03725-g007.jpg

相似文献

1
Gut Microbiota Reshaped by Pectin Treatment Improves Liver Steatosis in Obese Mice.果胶处理重塑肠道微生物群可改善肥胖小鼠的肝脂肪变性。
Nutrients. 2021 Oct 22;13(11):3725. doi: 10.3390/nu13113725.
2
Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.肝胆胰:多供体粪便微生物群移植通过重塑肠道微生物群来减轻高脂肪饮食诱导的小鼠肝脂肪变性。
J Gastroenterol Hepatol. 2023 Dec;38(12):2195-2205. doi: 10.1111/jgh.16359. Epub 2023 Oct 3.
3
Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.回肠胆汁酸转运蛋白抑制剂通过改善非酒精性脂肪性肝病模型小鼠肠道微生物失调改善肝脂肪变性。
mBio. 2021 Aug 31;12(4):e0115521. doi: 10.1128/mBio.01155-21. Epub 2021 Jul 6.
4
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.粪便微生物群操作可预防小鼠的菌群失调和酒精性肝损伤。
J Hepatol. 2017 Apr;66(4):806-815. doi: 10.1016/j.jhep.2016.11.008. Epub 2016 Nov 25.
5
Pectin Alleviates High Fat (Lard) Diet-Induced Nonalcoholic Fatty Liver Disease in Mice: Possible Role of Short-Chain Fatty Acids and Gut Microbiota Regulated by Pectin.果胶可缓解高脂(猪油)饮食诱导的小鼠非酒精性脂肪肝疾病:果胶调节的短链脂肪酸和肠道微生物的可能作用。
J Agric Food Chem. 2018 Aug 1;66(30):8015-8025. doi: 10.1021/acs.jafc.8b02979. Epub 2018 Jul 20.
6
Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.用白藜芦醇靶向肠道微生物群:管理肝脂肪变性的新证据的例证。
J Nutr Biochem. 2020 Jul;81:108363. doi: 10.1016/j.jnutbio.2020.108363. Epub 2020 Feb 27.
7
Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis gut microbiota.灵龟护肝汤减轻饮食诱导的肥胖和肝脂肪变性与肠道微生物群。
World J Gastroenterol. 2019 Jul 21;25(27):3590-3606. doi: 10.3748/wjg.v25.i27.3590.
8
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.果胶补充剂显著增强了用来自结直肠癌患者的肠道微生物群人源化的荷瘤小鼠的抗PD-1疗效。
Theranostics. 2021 Feb 19;11(9):4155-4170. doi: 10.7150/thno.54476. eCollection 2021.
9
Highly Branched RG-I Domain Enrichment Is Indispensable for Pectin Mitigating against High-Fat Diet-Induced Obesity.高度支化 RG-I 结构域富集对于果胶缓解高脂肪饮食诱导的肥胖是必不可少的。
J Agric Food Chem. 2020 Aug 12;68(32):8688-8701. doi: 10.1021/acs.jafc.0c02654. Epub 2020 Jul 29.
10
Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota.全粪便微生物移植通过有益调节肠道微生物群缓解高脂饮食诱导的小鼠非酒精性脂肪性肝炎。
Sci Rep. 2017 May 8;7(1):1529. doi: 10.1038/s41598-017-01751-y.

引用本文的文献

1
Citrus Pectin Supplementation Alleviated Hepatic Lipid Accumulation through Gut Microbiota Indole Lactic Acid Promoting Hepatic Bile Acid Synthesis and Excretion.补充柑橘果胶通过肠道微生物群吲哚乳酸促进肝脏胆汁酸合成与排泄减轻肝脏脂质积累。
Int J Biol Sci. 2025 Jul 28;21(11):5015-5033. doi: 10.7150/ijbs.116929. eCollection 2025.
2
Therapeutic Potential of Alginate-Pectin-Chitosan Encapsulated Pediococcus acidilactici Against Bile Duct Ligation-Induced Hepatic Fibrosis in Rats.海藻酸钠-果胶-壳聚糖包封的嗜酸乳杆菌对胆管结扎诱导的大鼠肝纤维化的治疗潜力
Probiotics Antimicrob Proteins. 2025 Jun 27. doi: 10.1007/s12602-025-10625-z.
3

本文引用的文献

1
Gut-microbiota-targeted diets modulate human immune status.靶向肠道微生物组的饮食可调节人体免疫状态。
Cell. 2021 Aug 5;184(16):4137-4153.e14. doi: 10.1016/j.cell.2021.06.019. Epub 2021 Jul 12.
2
Dietary Fibres Differentially Impact on the Production of Phenolic Acids from Rutin in an In Vitro Fermentation Model of the Human Gut Microbiota.膳食纤维对人肠道微生物群体外发酵模型中芦丁转化为酚酸的影响存在差异。
Nutrients. 2020 May 28;12(6):1577. doi: 10.3390/nu12061577.
3
The In Vitro Analysis of Prebiotics to Be Used as a Component of a Synbiotic Preparation.
Gut microbiota differences, metabolite changes, and disease intervention during metabolic - dysfunction - related fatty liver progression.
代谢功能障碍相关脂肪性肝病进展过程中的肠道微生物群差异、代谢物变化及疾病干预
World J Hepatol. 2025 Mar 27;17(3):103854. doi: 10.4254/wjh.v17.i3.103854.
4
Pectin-Zein-IPA nanoparticles promote functional recovery and alleviate neuroinflammation after spinal cord injury.果胶-玉米醇溶蛋白-异丙醇纳米颗粒促进脊髓损伤后的功能恢复并减轻神经炎症。
J Nanobiotechnology. 2025 Feb 28;23(1):152. doi: 10.1186/s12951-025-03224-1.
5
Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications, and therapeutic potentials.肝病中肠-肝轴的见解:机制、临床意义及治疗潜力
World J Gastrointest Pharmacol Ther. 2024 Nov 5;15(6):98146. doi: 10.4292/wjgpt.v15.i6.98146.
6
Extraction, Characterization, and Antioxidant Activity of Pectin from Lemon Peels.柠檬皮果胶的提取、表征及抗氧化活性研究。
Molecules. 2024 Aug 16;29(16):3878. doi: 10.3390/molecules29163878.
7
Therapeutic Potential of Pectin and Its Derivatives in Chronic Diseases.果胶及其衍生物在慢性疾病中的治疗潜力。
Molecules. 2024 Feb 18;29(4):896. doi: 10.3390/molecules29040896.
8
Non-alcoholic Steatohepatitis in Asians: Current Perspectives and Future Directions.亚洲人的非酒精性脂肪性肝炎:当前观点与未来方向
Cureus. 2023 Aug 2;15(8):e42852. doi: 10.7759/cureus.42852. eCollection 2023 Aug.
9
A Review of Pectin-Based Material for Applications in Water Treatment.用于水处理的果胶基材料综述。
Materials (Basel). 2023 Mar 9;16(6):2207. doi: 10.3390/ma16062207.
10
Pectin in Metabolic Liver Disease.代谢性肝病中的果胶。
Nutrients. 2022 Dec 29;15(1):157. doi: 10.3390/nu15010157.
用于共生制剂成分的益生元的体外分析。
Nutrients. 2020 Apr 30;12(5):1272. doi: 10.3390/nu12051272.
4
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.肠道微生物群与人类非酒精性脂肪性肝病:从代谢紊乱中解析微生物特征。
Nat Rev Gastroenterol Hepatol. 2020 May;17(5):279-297. doi: 10.1038/s41575-020-0269-9. Epub 2020 Mar 9.
5
The gut microbiota modulates both browning of white adipose tissue and the activity of brown adipose tissue.肠道微生物群调节白色脂肪组织的褐色化和棕色脂肪组织的活性。
Rev Endocr Metab Disord. 2019 Dec;20(4):387-397. doi: 10.1007/s11154-019-09523-x.
6
Steatosis and gut microbiota dysbiosis induced by high-fat diet are reversed by 1-week chow diet administration.高脂肪饮食引起的脂肪变性和肠道微生物群落失调可通过 1 周的普通饮食来逆转。
Nutr Res. 2019 Nov;71:72-88. doi: 10.1016/j.nutres.2019.09.004. Epub 2019 Oct 23.
7
The effect of antibiotics on the composition of the intestinal microbiota - a systematic review.抗生素对肠道微生物群落组成的影响——系统评价。
J Infect. 2019 Dec;79(6):471-489. doi: 10.1016/j.jinf.2019.10.008. Epub 2019 Oct 18.
8
The intestinal microbiota fuelling metabolic inflammation.肠道微生物群促进代谢性炎症。
Nat Rev Immunol. 2020 Jan;20(1):40-54. doi: 10.1038/s41577-019-0198-4. Epub 2019 Aug 6.
9
Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice.白藜芦醇诱导的肠道微生物群减少高脂肪饮食喂养的小鼠肥胖。
Int J Obes (Lond). 2020 Jan;44(1):213-225. doi: 10.1038/s41366-019-0332-1. Epub 2019 Feb 4.
10
Gut microbial metabolites in obesity, NAFLD and T2DM.肥胖、非酒精性脂肪性肝病和 T2DM 中的肠道微生物代谢产物。
Nat Rev Endocrinol. 2019 May;15(5):261-273. doi: 10.1038/s41574-019-0156-z.